01 June 2006
Cementless LCS Rotating Platform Knee Arthroplasty in Patients Over 60 Years Without Patella Replacement: A Mid-Term Clinical Outcome Study
George Papachristou, Spyros Plessas, John Sourlas, Efstathios Chronopoulos, Constantine Levidiotis, Spyros PnevmaticosMed Sci Monit 2006; 12(6): CR264-268 :: ID: 451253
Abstract
Background: The aim of this prospective paper is to present the resultsof a cementless LCS rotating-platform artificial knee design without resurfacing of the patella in patientsover 60 years of age. Material/Methods: In this prospective series, 234 patients were included with 251knees. The LCS rotating-platform uncemented design was used in all cases, without replacement of thepatella. Thirty-four patients were men and 200 were women. Two hundred three patients were sufferingfrom osteoarthrosis (10 bilateral) and 31 patients (7 bilateral) from rheumatoid arthritis. Seventeenpatients had a bilateral procedure. Prophylactic antibiotics and anticoagulants were also institutedto all patients. Results: Forty-nine patients developed deep vein thrombosis and responded well to theapplied conservative treatment. Overall results in the first 251 cementless cases at 2 to 9.8 years'follow-up (average: 5.7 years) were good to excellent in 94.4%, fair in 4.7%, and poor in 0.7%. Radiographsof the knees showed good bonding and no signs of radiolucency. The average clinical and functional KneeSociety Ratings were 21.07 points and 30.95 points, respectively, preoperatively and 87.95 points and78.56 points, respectively, at the final follow-up evaluation. Conclusions: With an average follow-upof 5.7 years, uncemented LCS rotating-platform knee joint arthroplasty without replacing the patellain patients over 60 years old was found to perform well, with encouraging clinical and radiological resultsand a survival rate of 98.1%.
Keywords: Aged, 80 and over, Arthritis, Rheumatoid - surgery, Arthroplasty, Replacement, Knee, Knee Joint - surgery, Knee Prosthesis, Osteoarthritis, Knee - surgery, Outcome Assessment (Health Care), Patella - surgery, Prosthesis Design, Stress, Mechanical
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952